Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | 131M | 132M |
| Cost of revenue | 95M | 96M |
| Gross profit | 35M | 35M |
| Research and development | 1M | 2M |
| Selling, general and administrative | 11M | 10M |
| Operating expenses | 38M | 38M |
| Operating income | −2M | −2M |
| Pre-tax income | −4M | −2M |
| Income tax | 3M | −547,821 |
| Net income | −6M | −2M |
| Earnings per share | −3.20 | −0.13 |
| Earnings per share, diluted | −3.20 | −0.13 |
| Weighted average shares | 2M | 10M |
| Weighted average shares, diluted | 2M | 10M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3M | 2M | 2M | 3M | 1M | 5M | 3M | 1M |
| Receivables | 14M | 14M | 18M |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | 673,220 | −7M |
| Depreciation and amortisation | 667,432 | 474,828 |
| Share-based compensation | 333,183 | 401,216 |
| Capital expenditure | 885,740 | 2M |
| Investing cash flow | −1M | −3M |
| Financing cash flow | −3M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 16M |
| 19M |
| 20M |
| 19M |
| 18M |
| Inventory | 14M | 15M | 12M | 13M | 13M | 14M | 14M | 13M |
| Current assets | 51M | 52M | 53M | 49M | 47M | 53M | 52M | 48M |
| Property, plant and equipment | 4M | 4M | 4M | 4M | 4M | 4M | 3M | 3M |
| Total assets | 68M | 70M | 73M | 72M | 68M | 75M | 75M | 70M |
| Current liabilities | 44M | 44M | 44M | 41M | 37M | 43M | 40M | 34M |
| Short-term debt | 13M | 12M | 14M | 13M | 13M | 15M | 12M | 10M |
| Total liabilities | 54M | 54M | 55M | 51M | 48M | 54M | 52M | 47M |
| Equity | 16M | 17M | 20M | 20M | 21M | 22M | 23M | 23M |
| Shares outstanding | 2M | 2M | 2M | 2M | 10M | 2M | 10M | 10M |
| Shares issued | 2M | 2M | 2M | 2M | 10M | 2M | 10M | 10M |
| 8M |